Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Psychiatry Res. 2017 Jul 31;257:303–308. doi: 10.1016/j.psychres.2017.07.065

Table 1.

Demographics of Participants in Clinical Antidepressant Trials

No active SI during research participation (n = 206) Active SI during research participation (n = 63)

Mean(SD) Mean(SD) t p
Age 43.54(11.69) 45.54(12.98) 1.16 .25
Age of Onset 21.65(10.95) 18.56(11.07) 1.94 .054
MADRS Score at Baseline (suicide item removed) 28.74(6.37) 32.02(6.32) 3.16 .002
MADRS Suicide Item at Baseline 1.25(0.89) 2.95(1.09) 11.92 <.001
N(%) N(%) X2 p
Gender 2.56 .11
 Male 94(46) 36(57)
 Female 112(54) 27(43)
Diagnoses 8.13 .02
 Bipolar I 19(9) 12(19)
 Bipolar II 13(6) 8(13)
 MDD 174(84) 43(68)
History of Suicide Attempt 32(16) 26(41) 15.54 <001
Comorbid Diagnosis 122(59) 32(51) 1.40 .24
History of Abuse 85(41) 23(37) 0.53 .47
Substance Abuse History 77(37) 29(46) 1.95 .16
TRD Protocol 154(75) 56(89) 5.63 .02
Completed Study 159(77) 42(67) 2.82 .09

SI: suicidal ideation; MADRS: Montgomery-Asberg Depression Rating Scale; MDD: major depressive disorder; TRD: treatment-resistant depression

HHS Vulnerability Disclosure